Peptide‒drug conjugates (PDCs) are drug delivery systems consisting of a drug covalently
coupled to a multifunctional peptide via a cleavable linker. As an emerging prodrug strategy …

The self-assembly of low-molecular-weight building motifs into supramolecular polymers
has unlocked a new realm of materials with distinct properties and tremendous potential for …

Self-assembled nanomedicine holds great potential in cancer theragnostic. The structures
and dynamics of nanomedicine can be affected by a variety of non-covalent interactions, so …

Drug self‐delivery systems (DSDSs) offer new ways to create novel drug delivery systems
(DDSs). In typical DSDSs, therapeutic reagents are not considered passive cargos but active …

Camptothecin (CPT) is a highly cytotoxic molecule with excellent antitumor activity against
various cancers. However, its clinical application is severely limited by poor water solubility …

It is challenging to manage inflammatory diseases using traditional anti‐inflammatory drugs
due to their limited efficacy and systemic side effects, which are a result of their lack of …

Amongst the several nano-drug delivery systems, lipid or polymer-based core–shell
nanocapsules (NCs) have garnered much attention of researchers owing to its …

Bacterial infections cause severe health conditions, resulting in a significant economic
burden for the public health system. Although natural phytochemicals are considered …

Nanotechnological interventions for cancer immunotherapy are a rapidly evolving paradigm
with immense potential. Self-assembled nanobiomaterials present safer alternatives to their …

Drug self-delivery systems (DSDSs) have been extensively exploited to enhance drug
loading capacity and avoid excipient-related toxicity issues. However, deficient tumor …